Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA095137-02
Application #
6704768
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Howcroft, Thomas K
Project Start
2003-02-14
Project End
2008-01-31
Budget Start
2004-02-01
Budget End
2005-01-31
Support Year
2
Fiscal Year
2004
Total Cost
$303,379
Indirect Cost
Name
University of California San Francisco
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Morvan, Maelig G; Champsaur, Marine; Reizis, Boris et al. (2017) Chronic In Vivo Interaction of Dendritic Cells Expressing the Ligand Rae-1? with NK Cells Impacts NKG2D Expression and Function. Immunohorizons 1:10-19
Weinger, Jason G; Plaisted, Warren C; Maciejewski, Sonia M et al. (2014) Activating receptor NKG2D targets RAE-1-expressing allogeneic neural precursor cells in a viral model of multiple sclerosis. Stem Cells 32:2690-701
Beaulieu, Aimee M; Bezman, Natalie A; Lee, Jang Eun et al. (2013) MicroRNA function in NK-cell biology. Immunol Rev 253:40-52
Lanier, Lewis L (2013) Shades of grey--the blurring view of innate and adaptive immunity. Nat Rev Immunol 13:73-4
Kim, Charles C; Lanier, Lewis L (2013) Beyond the transcriptome: completion of act one of the Immunological Genome Project. Curr Opin Immunol 25:593-7
Min-Oo, Gundula; Kamimura, Yosuke; Hendricks, Deborah W et al. (2013) Natural killer cells: walking three paths down memory lane. Trends Immunol 34:251-8
Benoist, Christophe; Lanier, Lewis; Merad, Miriam et al. (2012) Consortium biology in immunology: the perspective from the Immunological Genome Project. Nat Rev Immunol 12:734-40
Orr, Mark T; Lanier, Lewis L (2011) Inhibitory Ly49 receptors on mouse natural killer cells. Curr Top Microbiol Immunol 350:67-87
Sun, Joseph C; Lopez-Verges, Sandra; Kim, Charles C et al. (2011) NK cells and immune ""memory"". J Immunol 186:1891-7
Orr, Mark T; Lanier, Lewis L (2011) Natural killer cell licensing during viral infection. Adv Exp Med Biol 780:37-44

Showing the most recent 10 out of 44 publications